These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9853514)
21. Modification of retroviral tropism by display of IGF-I. Chadwick MP; Morling FJ; Cosset FL; Russell SJ J Mol Biol; 1999 Jan; 285(2):485-94. PubMed ID: 9878423 [TBL] [Abstract][Full Text] [Related]
22. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors. Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951 [TBL] [Abstract][Full Text] [Related]
23. Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library. Engelstädter M; Bobkova M; Baier M; Stitz J; Holtkamp N; Chu TH; Kurth R; Dornburg R; Buchholz CJ; Cichutek K Hum Gene Ther; 2000 Jan; 11(2):293-303. PubMed ID: 10680843 [TBL] [Abstract][Full Text] [Related]
24. Construction and use of a safe and efficient amphotropic packaging cell line. Markowitz D; Goff S; Bank A Virology; 1988 Dec; 167(2):400-6. PubMed ID: 2462307 [TBL] [Abstract][Full Text] [Related]
25. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Schnierle BS; Moritz D; Jeschke M; Groner B Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165 [TBL] [Abstract][Full Text] [Related]
26. Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe. Lorimer IA; Lavictoire SJ J Immunol Methods; 2000 Apr; 237(1-2):147-57. PubMed ID: 10725459 [TBL] [Abstract][Full Text] [Related]
27. Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions. Spitzer D; Dittmar KE; Rohde M; Hauser H; Wirth D J Virol; 2003 May; 77(10):6070-5. PubMed ID: 12719600 [TBL] [Abstract][Full Text] [Related]
28. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706 [TBL] [Abstract][Full Text] [Related]
29. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
30. Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. Jiang A; Chu TH; Nocken F; Cichutek K; Dornburg R J Virol; 1998 Dec; 72(12):10148-56. PubMed ID: 9811755 [TBL] [Abstract][Full Text] [Related]
32. Sub-retroviral particles as gene transfer vectors that by-pass retrovirus-receptor interaction restrictions. Janka I; Günzburg WH; Brem G; Erfle V; Salmons B Biochem Mol Biol Int; 1993 Oct; 31(2):349-57. PubMed ID: 8275023 [TBL] [Abstract][Full Text] [Related]
33. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159 [TBL] [Abstract][Full Text] [Related]
34. Differential interaction of retroviral vector with target cell: quantitative effect of cellular receptor, soluble proteoglycan, and cell type on gene delivery efficiency. Kwon YJ; Peng CA Tissue Eng Part A; 2008 Sep; 14(9):1497-506. PubMed ID: 18620488 [TBL] [Abstract][Full Text] [Related]
35. Fusogenic effects of murine retroviruses and cationic enhancers of transduction. Xu G; Solaiman F; Zink MA; Hodgson CP Cancer Gene Ther; 2000 Jan; 7(1):53-8. PubMed ID: 10678356 [TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Patijn GA; Lieber A; Schowalter DB; Schwall R; Kay MA Hepatology; 1998 Sep; 28(3):707-16. PubMed ID: 9731563 [TBL] [Abstract][Full Text] [Related]
37. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320 [TBL] [Abstract][Full Text] [Related]
38. Targeting of retroviral vectors through protease-substrate interactions. Nilson BH; Morling FJ; Cosset FL; Russell SJ Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159 [TBL] [Abstract][Full Text] [Related]
39. Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus. Konetschny C; Holzer GW; Urban C; Hämmerle T; Mayrhofer J; Falkner FG J Virol; 2003 Jun; 77(12):7017-25. PubMed ID: 12768020 [TBL] [Abstract][Full Text] [Related]
40. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice. Gao C; Sands MS; Haskins ME; Ponder KP Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]